With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|SWI/SNF Complex and Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia||Dana-Farber Cancer Institute / Jennifer Wu||Young Investigator Grants||2012||Massachusetts|
|Targeting Neovascularization in Graft-Versus-Host Disease||Memorial Sloan-Kettering Cancer Center / Marcel van den Brink, MD/PhD||Innovation Grants||2012||New York|
|Targeting the ETS Transcription Factor Rearrangement EWS/FLI in Ewing sarcoma||Dana-Farber Cancer Institute / Kimberly Stegmaier, MD||Bridge Grants||2012||Massachusetts|
|Texas Children's Cancer Center Alex's Lemonade Stand Center of Excellence||Baylor College of Medicine / Stacey Berg, MD - Scholars: Jennifer Foster, MD, MPH and Ron Bernardi, MD,PhD||Center of Excellence Grants||2012||Texas|
|The role of NOTCH1 in T-cell acute lymphoblastic leukemia.||Columbia University Medical Center / Adolfo Ferrando||Bridge Grants||2012||New York|
|The role of vitamin D in hepatoblastoma formation and prevention||Brigham and Women's Hospital / Wolfram Goessling, MD/PhD||Innovation Grants||2012||Massachusetts|
|Transcriptome Sequencing (RNA-Seq) for Identification of Novel Markers of Disease Outcome and Therapeutic Targets in Acute Myeloid Leukemia||Fred Hutchinson Cancer Research Center / Fabiana Ostronoff, MD||Young Investigator Grants||2012||Washington|
|Treatment for human hepatoblastoma based on recombinant adeno-associated virus vectors||University of Florida / Chen Ling||Young Investigator Grants||2012||Florida|
|V alpha-invariant NKT cells as a novel platform for cancer immunotherapy||Baylor College of Medicine / Leonid Metelitsa, MD, PhD||Innovation Grants||2012||Texas|